Successful UVA1 phototherapy in a patient with scleredema adultorum

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 2, 2005, Pages 203-204

  Eberlein Konig B ^a   Vogel, M ^a   Katzer, K ^a   Hein, R ^a   Kohn F M ^a   Ring, J ^a   Abeck, D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Medium dose UVA1 irradiation; Phototherapy; Scleredema adultorum

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CONNECTIVE TISSUE DISEASE; DENSITY; DISEASE DURATION; ECHOGRAPHY; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; SCLERODERMA; SKIN DISEASE; THICKNESS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SCLEREDEMA ADULTORUM; ULTRAVIOLET THERAPY;

EID: 16244374948     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.00935.x     Document Type: Article

References (14)

1. Varga J, Gotta S, Li L, Di Leonardo M. Scleredema adultorum: a case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro. Br J Dermatol 1995; 132: 992-999.
2. Hager CM, Sobhi HA, Hunzelmann N et al. Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998; 38: 240-242.
3. Grundmann-Kollmann M, Ochsendorf TM, Zollner K et al. Cream PUVA therapy for scleredema adultorum. Br J Dermatol 2000; 142: 1058.
4. Stege H, Berneburg M, Humke S et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
5. Camacho NR, Sanchez JE, Marin RF et al. Medium-dose UVA-1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001; 45: 697-699.
6. Kerscher M, Volkenandt M, Gruss C et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
7. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
8. Ghoreschi K, Röcken M. Efficacy of photochemotherapy and UVA-1 therapy in patients with morphea or lichen sclerosus. Photodermatol Photoimmunol Photomed 2002; 18: 104.
9. Gruss CJ, von Kobyletzki G, Behrens-Williams SC et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 149-155.
10. Kreuter A, Gambichler T, Avermaete A et al. Combined treatment of calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 2001; 18: 241-245.
11. Abeck D, Schmidt T, Fesq H et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-257.
12. Mempel M, Schmidt T, Boeck K et al. Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy. Br J Dermatol 2000; 142: 473-480.
13. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-637.
14. Brinckmann J, Neess CM, Gaber Y et al. Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. J Invest Dermatol 2001; 11: 269-273.